GRIA2 and Parkinson disease: Specifically, the decreased expression of GluA1 limited long-term potentiation, while the increased expression of GluA2/3 enhanced ionic interactions with Na+ and Ca2+, impaired Mg2+ influx, and restored normal synaptic transmission in the nigrostriatal pathway in PD animal models.